Urinary PCA3 a Superior Diagnostic Biomarker for Prostate Cancer among Ghanaian Men

Table 1

Distribution of prostate disorders among the study participants.

Variable	Biopsy results
Age groups (years)	PCa (%)	BPH (%)	Prostatitis (%)	Number ()
40–49	4 (6.4%)	12 (10.4%)	7 (11.9%)	23
50–9	13 (20.6%)	43 (37.4%)	26 (44.1%)	82
60–69	17 (27.0%)	34 (29.6%)	17 (28.8%)	68
70–79	22 (34.9%)	22 (19.1%)	8 (15.5%)	52
>80	7 (11.1%)	4 (3.5%)	1 (1.7%)	12
Total	63	115	59	237

PCa: prostate cancer; BPH: benign prostatic hyperplasia.